BrosMed Announces CE Mark and Launch for Conger™ Hydrophilic Coated Wire
Release time:
2016-03-13
BrosMed Announces CE Mark and Launch for Conger™ Hydrophilic Coated Wire March 15, 2016—BrosMed announced CE Mark and Launch of its Conger™ hydrophilic coated wire for peripheral vasculature during diagnostic and interventional procedures.
BrosMed Announces CE Mark and Launch for Conger™ Hydrophilic Coated Wire
March 15, 2016—BrosMed announced CE Mark and Launch of its Conger™ hydrophilic coated wire for peripheral vasculature during diagnostic and interventional procedures.
The Conger™ Hydrophilic Guidewire is constructed from a high quality, steerable metallic alloy core wire with a polymer coating utilizing a sophisticated construction process to improve crossability of guidewire. The hydrophilic coating is applied over the radiopaque polymer jacket to reduce the friction.
As part of the BrosMed Medical product portfolio, the Conger™ hydrophilic coated wire will definitely enhance company’s penetration to the market along with existing products like Artimes™ PTCA, Apollo™ PTCA, Minerva™ 0.018 PTA, Achilles™ NC 0.018 PTA, Polux™ 0.014 PTA, Castor™ NC 0.014, Atropos™ 0.035, Hermes™ NC 0.035 PTA and series of accessories.
“The wide range of the Conger™ hydrophilic coated wire from 45 to 260cm length with diameter from 0.025” to 0.038” will cover most of clinical need and we believe the launch of Conger™ wire will enhance BrosMed brand in the market and keep us competitive from others”. said by Jos A.W.J de Korte, General Manager of BrosMed Medical B.V., the Netherlands, the marketing and sales center of BrosMed Medical in Europe.
Please contact our regional distributors and/or our sales at sales@brosmed.com or cs@brosmed.eu or office +31 850 14 09 01 for more products details.
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26